无细胞百白破联合疫苗,DTaP
1)DTaP无细胞百白破联合疫苗
1.STUDY ON THE IMMUNOGENICITY AND SAFETY OF DTaP;无细胞百白破联合疫苗安全性和免疫原性研究
英文短句/例句

1.A Study on Immunogenicity and Safety of Adsorbed Acellular DTP Vaccine Prepared with Separately Purified Antigens三组分的无细胞百白破联合疫苗安全性和免疫原性研究
2.Adsorption of Non-cell DTP Vaccine and the Effectiveness of the Preparation Process and Toxicity Studiess吸附无细胞百白破联合疫苗的制备工艺及效力与毒性方面的研究
3.Immune Persistence of Domestic Adsorhed Acellular Diphtheria Tetanus and Pertussis Combined Vaccine国产吸附无细胞白百破联合疫苗的免疫持久性
4.Pilot Production Procedure of Adsorbed Acellular DTP-Recombinant Hepatitis B(CHO Cells)Combined Vaccine吸附无细胞百白破-重组乙型肝炎(CHO细胞)联合疫苗的中试工艺
5.Observation on efficacy of whole cell DTP-HBV combined vaccine吸附全细胞百白破乙肝四联疫苗效果观察
6.Serum Antibody Level of Children One Year after A Booster of Acellular DTP无细胞百白破疫苗加强免疫一年后的血清抗体水平
7.Comparison on the Safety of Two kinds of DTP Vaccines两种百白破联合疫苗接种安全性比较
8.observation on the Efficacy of Hepatstis B Vaccine Combined lmmune with BCG and DPT乙型肝炎疫苗与卡介苗、百白破混合菌苗的联合免疫效果观察
9.combined diphtheria/pertussis/tetanus vaccine白喉/百日咳/破伤风/三联疫苗
10.d tetanus vaccine百日咳白喉破伤风三联疫苗
11.Immune Response of HB and DPT Vaccines Using BCG as An Adjuvant卡介苗优化乙型肝炎疫苗、白百破三联疫苗的免疫应答作用
12.diphtheria-pertussis-tetanus vaccine [DPT vaccine]白喉、百日咳、破伤风混合疫苗
13.DPT [diphtheria, pertussis, tetanus] vaccine白喉、百日咳及破伤风混合疫苗
14.Study on the Immune Effect of Simultaneous Inoculation of Hepatitis B with DTP and OPV乙型肝炎疫苗与百白破联合制剂、脊髓灰质炎疫苗同时接种的免疫效果研究
15.Studies on the stability of DTP-rHB combined vaccine吸附百日咳、白喉、破伤风、乙肝联合疫苗的稳定性研究
16.three-dosage diphtheria/pertussis/tetanus vaccine (DPT III)分三次接种的白喉、百日咳、破伤风三联疫苗
17.Studies on the Stability of Recombinant Hepatitis B DTP Combined Vaccine基因工程乙肝-百白破四联疫苗稳定性研究
18.Construction of Eukaryotic Expression Vector of Chicken Interleukin IL-18 and Its Combined Immunity with ILTV Attenuated Vaccine鸡白细胞介素-18真核表达载体构建与ILTV弱毒疫苗联合免疫
相关短句/例句

Acellular DTP无细胞百白破三联疫苗
3)Adsorhed acellular diphtheria tetanus and pertussis combined vaccine吸附无细胞白百破联合疫苗
4)DTaP vaccine无细胞百白破疫苗
1.By descriptively analyzing data from WHO and domestic data,it is found that acellular pertussis,diphtheria and tetanus combined vaccine(DTaP) is safer and similarly effective compared with the old one,and it had been include into the EPI in more than 78 countries,and DTaP vaccine is available in China now.利用描述性分析方法,对世界卫生组织、我国关于无细胞百白破疫苗研究的资料进行分析,以了解该疫苗的使用情况。
5)local DTaP vaccine国产无细胞百白破疫苗
6)imported DTaP vaccine进口无细胞百白破疫苗
1.Objective To compare the vaccine reaction of the local and imported DTaP vaccine.目的比较国产无细胞百白破疫苗与进口无细胞百白破疫苗接种反应差异。
延伸阅读

白百破三联疫苗白百破三联疫苗diphtheria?pertussis?tetanus triunion vaccins 即白喉类毒素、百日咳菌苗和破伤风类毒素的混合制剂。引起主动免疫,对白喉、百日咳及破伤风有预防作用。具体接种方案是,从出生2~3个月起,每隔4~6周注射1次,共3次,第一次量约0.5ml,余两次各1ml。2岁左右进行第一次强化注射,剂量1ml,4~5岁时进行第二次强化注射,剂量1ml,以后每10岁强化一次。免疫接种保护率85%以上。